NO992980D0 - Nitroimidazol gelblanding - Google Patents

Nitroimidazol gelblanding

Info

Publication number
NO992980D0
NO992980D0 NO992980A NO992980A NO992980D0 NO 992980 D0 NO992980 D0 NO 992980D0 NO 992980 A NO992980 A NO 992980A NO 992980 A NO992980 A NO 992980A NO 992980 D0 NO992980 D0 NO 992980D0
Authority
NO
Norway
Prior art keywords
nitroimidazole
gel mixture
water
skin
bydroxyalkyl
Prior art date
Application number
NO992980A
Other languages
English (en)
Other versions
NO992980L (no
Inventor
Michael Goodman
Ke Lindahl
Original Assignee
Bioglan Ireland R & D Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10804765&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO992980(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bioglan Ireland R & D Ltd filed Critical Bioglan Ireland R & D Ltd
Publication of NO992980D0 publication Critical patent/NO992980D0/no
Publication of NO992980L publication Critical patent/NO992980L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Colloid Chemistry (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO992980A 1996-12-20 1999-06-17 Nitroimidazol gelpreparat NO992980L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9626513.7A GB9626513D0 (en) 1996-12-20 1996-12-20 A pharmaceutical composition
PCT/GB1997/003512 WO1998027960A2 (en) 1996-12-20 1997-12-19 A nitroimidazole gel composition

Publications (2)

Publication Number Publication Date
NO992980D0 true NO992980D0 (no) 1999-06-17
NO992980L NO992980L (no) 1999-08-16

Family

ID=10804765

Family Applications (1)

Application Number Title Priority Date Filing Date
NO992980A NO992980L (no) 1996-12-20 1999-06-17 Nitroimidazol gelpreparat

Country Status (17)

Country Link
US (1) US6348203B1 (no)
EP (1) EP0946143B1 (no)
JP (1) JP2001507018A (no)
KR (1) KR20000069606A (no)
AT (1) ATE323466T1 (no)
AU (1) AU730812B2 (no)
CA (1) CA2275429A1 (no)
DE (1) DE69736998T2 (no)
DK (1) DK0946143T3 (no)
ES (1) ES2263183T3 (no)
GB (1) GB9626513D0 (no)
IE (1) IES970906A2 (no)
NO (1) NO992980L (no)
NZ (1) NZ336258A (no)
PT (1) PT946143E (no)
WO (1) WO1998027960A2 (no)
ZA (1) ZA9711455B (no)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2232855C (en) * 1997-04-10 2007-10-09 Roche Consumer Health (Worldwide) Sa Pharmaceutical formulation
US7258869B1 (en) 1999-02-08 2007-08-21 Alza Corporation Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
CA2379270C (en) * 1999-07-16 2007-04-10 Nishizumi Nishimuta External preparation for skin diseases containing nitroimidazole
JP2002212073A (ja) * 2001-01-15 2002-07-31 Shoei:Kk 水性液剤
SE0103528D0 (sv) 2001-10-21 2001-10-21 Jan Faergeman Topiska kompositioner med förstärkt effekt
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
SE0301862D0 (sv) * 2003-06-26 2003-06-26 Jan Faergeman Sätt att inhibera tillväxten av mot antibiotika resistenta bakterier
US7456207B2 (en) * 2003-09-25 2008-11-25 Teva Pharmaceuticals Usa, Inc. Vaginal pharmaceutical compositions and methods for preparing them
FR2866568B1 (fr) * 2004-02-20 2007-08-24 Galderma Res & Dev Utilisation du metronidazole pour la preparation d'une composition pharmaceutique destinee a traiter un desordre de la vascularisation cutanee
FR2866570B1 (fr) * 2004-02-20 2007-08-24 Galderma Res & Dev Utilisation du metronidazole pour la preparation d'une composition pharmaceutique destinee a traiter une inflammation cutanee
FR2866569B1 (fr) * 2004-02-20 2007-08-24 Galderma Res & Dev Utilisation du metronidazole pour la preparation d'une composition pharmaceutique destinee a traiter des pathologies liees au recepteur de type b de l'interleukine 8 et/ou au recepteur de type 1 de pacap
US20060093675A1 (en) * 2004-10-29 2006-05-04 Mathew Ebmeier Intravaginal treatment of vaginal infections with metronidazole compositions
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
DE602007009377D1 (de) 2006-05-30 2010-11-04 Intarcia Therapeutics Inc Zweiteiliger flussmodulator mit einem internen kanal für ein osmotisches ausgabesystem
US7682356B2 (en) 2006-08-09 2010-03-23 Intarcia Therapeutics, Inc. Osmotic delivery systems and piston assemblies for use therein
US8258164B2 (en) * 2006-09-12 2012-09-04 Curatek Pharmaceuticals Holding, Inc. Nitroimidazole composition and method
JP5238295B2 (ja) * 2007-03-09 2013-07-17 第一三共ヘルスケア株式会社 低刺激性透明半固形外用剤
JP5351884B2 (ja) 2007-04-23 2013-11-27 インターシア セラピューティクス，インコーポレイティド インスリン分泌促進性ペプチドの懸濁製剤及び使用
DE102008006394A1 (de) * 2008-01-28 2009-07-30 Beiersdorf Ag Verwendung von Wirkstoffkomplexen aus Panthenol, Glycerin, Citrat und/oder Bisabolol gegen Pollenallergien
CA2726861C (en) 2008-02-13 2014-05-27 Intarcia Therapeutics, Inc. Devices, formulations, and methods for delivery of multiple beneficial agents
US20100105750A1 (en) * 2008-10-23 2010-04-29 Nycomed Us Inc. Stable metronidazole gel formulations
HUE035862T2 (en) 2009-09-28 2018-05-28 Intarcia Therapeutics Inc Rapid development and / or completion of substantially steady-state drug delivery
EP2498764B1 (en) 2009-11-09 2017-09-06 Spotlight Technology Partners LLC Fragmented hydrogels
NZ599524A (en) 2009-11-09 2014-04-30 Spotlight Technology Partners Llc Polysaccharide based hydrogels
US8618175B2 (en) * 2010-07-19 2013-12-31 Brussels Ventures Corp. Ultrasound medical gel composition etherified hydroxyethylcellulose
JP5954928B2 (ja) * 2010-11-19 2016-07-20 大同化成工業株式会社 皮膚潰瘍処置用外用剤のゲル状基剤
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
CN103763925A (zh) 2011-06-28 2014-04-30 梅迪奇制药有限公司 高剂量粘膜粘附甲硝唑水基凝胶制剂及其治疗细菌性***病的用途
WO2014100569A1 (en) * 2012-12-20 2014-06-26 Medicis Pharmaceutical Corporation High dosage topical metronidazole gel formulations
EP3013368A1 (en) 2013-06-25 2016-05-04 Mission Pharmacal Company Novel formulations for the treatment of vaginal disorders
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
ES2968262T3 (es) 2015-06-03 2024-05-08 I2O Therapeutics Inc Sistemas de colocación de implantes
EP3365022A4 (en) * 2015-10-25 2019-07-24 IVIEW Therapeutics, Inc. PHARMACEUTICAL FORMULATIONS THAT FORM A GEL IN SITU
WO2017200943A1 (en) 2016-05-16 2017-11-23 Intarcia Therapeutics, Inc. Glucagon-receptor selective polypeptides and methods of use thereof
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
CN110225762A (zh) 2017-01-03 2019-09-10 因塔西亚制药公司 包括glp-1受体激动剂的连续施用和药物的共同施用的方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3421443C2 (de) * 1984-06-08 1996-09-05 Daicel Chem Stabile Gelmasse und Verfahren zu ihrer Herstellung
US5536743A (en) * 1988-01-15 1996-07-16 Curatek Pharmaceuticals Limited Partnership Intravaginal treatment of vaginal infections with buffered metronidazole compositions
GB2229443A (en) * 1989-03-07 1990-09-26 American Cyanamid Co Wound dressings
CA2011423A1 (en) * 1989-03-07 1990-09-07 Peter M. Taylor Pharmaceutical compositions useful as drug delivery vehicles and/or as wound dressings
CA1337279C (en) * 1989-06-06 1995-10-10 Robert J. Borgman Intravaginal treatment of vaginal infections with buffered metronidazole compositions
ATE214592T1 (de) * 1990-12-21 2002-04-15 Felice Bombart Wässrige vaginaldusche und deren anwendung
GB9105995D0 (en) * 1991-03-21 1991-05-08 Smith & Nephew Wound dressing
US5662924A (en) * 1991-03-21 1997-09-02 Smith & Nephew Plc Wound dressing
SE506509C2 (sv) * 1992-04-14 1997-12-22 Bioglan Ab Användning av imidazoler för framställning av en farmaceutisk formulering för behandling av inflammatoriska och/eller infektiösa hudsjukdomar
US5391367A (en) * 1993-07-28 1995-02-21 Pfizer Inc. Antifungal nail solution

Also Published As

Publication number Publication date
AU5330898A (en) 1998-07-17
US6348203B1 (en) 2002-02-19
CA2275429A1 (en) 1998-07-02
NZ336258A (en) 2001-04-27
EP0946143B1 (en) 2006-04-19
DE69736998T2 (de) 2007-03-01
IES80590B2 (en) 1998-10-07
WO1998027960A3 (en) 1998-09-11
DK0946143T3 (da) 2006-08-21
ES2263183T3 (es) 2006-12-01
ZA9711455B (en) 1998-09-02
GB9626513D0 (en) 1997-02-05
NO992980L (no) 1999-08-16
IES970906A2 (en) 1998-10-07
JP2001507018A (ja) 2001-05-29
PT946143E (pt) 2006-08-31
KR20000069606A (ko) 2000-11-25
WO1998027960A2 (en) 1998-07-02
EP0946143A2 (en) 1999-10-06
ATE323466T1 (de) 2006-05-15
DE69736998D1 (de) 2007-01-04
AU730812B2 (en) 2001-03-15

Similar Documents

Publication Publication Date Title
NO992980D0 (no) Nitroimidazol gelblanding
AR002944A1 (es) Uso de una composicion de gel acuosa que contiene una o mas drogas que son eficaces para tratar hemorroides para la preparacion de un medicamento y dicha composicion de gel acuosa
ATE274900T1 (de) Stabilgelmischung in form einer mischung eines öligen gels und eines wässrigen gels
DE69032125D1 (de) Gelwundverbandszusammensetzungen und verfahren zu deren gebrauch
UA41989C2 (uk) Фармацевтична композиція у вигляді гелю для лікування захворювань шкіри та спосіб лікування інфікованої шкіри
BR0008787A (pt) Sistema à base de colágeno injetável para aplicação de células ou agentes terapêuticos
AU2526095A (en) Transdermal device for administration through de-epithelialized skin
DE69617723D1 (de) Wachsumsfaktoren enthaltende gelformulierungen
ES2163530T3 (es) Aplicacion de superoxido dismutasa (sod) en liposomas.
DE59209658D1 (de) Pharmazeutische zusammensetzung zur wund-, narben- und keloidbehandlung
EP0640647A3 (en) Ion-crosslinked glycosaminoglycan gels to increase soft tissue and for drug delivery.
DE60103894D1 (de) Sprühfähige wundversorgungszusammensetzung
RU96124095A (ru) Применение геля в качестве протравителя
HUP9602498A2 (hu) Antimikrobiális hatású gyógyászati készítmények
FR2542616B1 (fr) Composition pour le traitement des muqueuses a base d'un antibiotique et d'un hydrocolloide formateur de gel
DE60002719D1 (de) Ophthalmische zusammensetzungen in form wässriger gele
BR9908713A (pt) Uso de selegilina ou desmetil-selegilina para tratamento de feridas, queimaduras e danos dermatológicos
BR9903751A (pt) Composição para uso cosmético e/ou dermatológico, utilização cosmética da composição, utilização da composição e utilização de pelo menos um ácido aminossulfÈnico n-substituìdo
FR2719475B1 (fr) Composition cosmétique et/ou dermatologique à gélifiant polymérique cationique, ses utilisations notamment pour la dépigmentation de la peau.
PT1140001E (pt) Composicao para tratamento de queimaduras
AR017170A1 (es) Composicion oftalmologica
RS50184B (sr) Preparat na bazi enzima mukopolisaharidaze za tretiranje celulita i postupak za njegovo dobijanje
TH9143A (th) ส่วนประกอบของเจบทาแผลและวิธีการใช้
ES281238U (es) Parche antiarrugas y-o para los cuidados de la piel
TH9143EX (th) ส่วนประกอบของเจบทาแผลและวิธีการใช้

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application